|Acquired by||Biotie Therapies|
|Debt, 2/2010 ||$1.7M|
|Debt, 10/2011 ||$1.08M|
Neurelis, Inc., a specialty pharmaceutical company, licenses, develops, and commercializes product candidates for epilepsy and the broader central nervous system (CNS) market. The company was incorporated in 2007 and is based in Encinitas, California.